Check Up Archive: June, 2013

Fleet Enema label misleads – it’s not just “saline”

Comment icon 0 Comments
In 2006 the FDA warned consumers about kidney failure seen in some users of oral sodium phosphates (OSP) like Fleet’s Phospho-soda. FDA’s... Read more

Nice bonds for conservative investors

Comment icon 0 Comments
A monthly review of Big Cap pharma stocks by Sanford Bernstein, a large fee-analyst company, offers some insights in what it says and what... Read more

Patient friendly service or danger up ahead?

Comment icon 0 Comments
Doctors sometimes provide patients with drug samples to get them started on a needed medication in a timely manner. Hospital emergency departments... Read more

The reactionary myth that's letting finance managers ruin pharma companies

Comment icon 0 Comments
Pharma's finance managers have come in for some heavy hits in this space during the past two years. They deserve every swat and then some... Read more

Avoid look-alike medication mistakes

Comment icon 0 Comments
We often receive reports from people who took the wrong medicine or the wrong dose because of mix-ups with products that looked similar. Sometimes... Read more

Pharma as a fading power hitter

Comment icon 0 Comments
Approximately half the drugs now in clinical development involve an approach known as targeted therapy. Last week's posting discussed some... Read more

Children's Hospital of Philadelphia tops rankings for third year

Comment icon 0 Comments
For the third consecutive year, Children’s Hospital of Philadelphia has landed in the top spot on U.S. News & World Report’s... Read more

Pharma needs an R&D strategy

Comment icon 0 Comments
Recently a knowledgeable pharma veteran lamented the fact that the industry has not widely adopted what he considers a particularly useful... Read more